top of page

The Inflation Reduction Act’s harms go beyond drug pricing — they’re threatening your Medicare

The Inflation Reduction Act’s drug price-setting provisions have drawn significant rebuke from experts who argue that many clinical programs will ultimately be killed or never get started as a result of the act’s deleterious effects on innovation. What isn’t getting attention is how the law is reshaping Medicare in big ways.  


Commenti


bottom of page